GlobeNewswire

SmartCash Announces Success of Community-Approved Initiatives Funded by SmartHive Project Treasury

Dela

Recent accomplishments by proactive community members demonstrate effectiveness of remarkable community-centric design

NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- SmartCash, a community governance, cooperation and growth focused crypto-asset created via blockchain technology, today provides a recap of its completed community initiatives. Each project was made possible via the SmartHive Project Treasury, which is funded by a portion of the block rewards and then directed via SmartCash holders who participate in SmartVoting.

Building the Future

Proposals to the SmartCash community include nearly as many ideas as there are participants, with each garnering its share of interest in the voting process for SmartHive funding support. The 22 successful projects funded and completed include:

  • Sponsorship of the largest innovation and technology event in Mexico where tens of thousands gathered and could watch a presentation on SmartCash
  • A month-long program that provided up to 2,500 meals every Sunday to feed hungry people in Venezuela and teach them about self-reliance through SmartCash
  • Introduction of SmartCash at one of the top business schools in France via a SmartEvent conference tailored to university students
  • Creating, funding and running a soccer program for vulnerable children and young adults in Brazil
  • Introduction of SmartCash to students and teachers at five universities in Ghana
  • Production of Actuarial Blockchain Educational Videos that feature the potential and rewards of blockchain technology in finance
  • Expansion of the SmartCash Roadshow in Ghana to merchants seeking avenues to exchange cryptocurrencies for goods and services in Africa
  • Sponsorship of a Mexican MMA fighter
  • Listing SmartCash on MasterNodes.Online to increase visibility among cryptocurrency enthusiasts  
  • Development of a university-level crypto-course featuring SmartCash
  • Training dozens of Cameroonian youths to become financially literate through the use of SmartCash in entrepreneurial pursuits
  • Promote SmartCash at a crypto-blockchain event on the Smart Services Campus in the Netherlands

Expanding the SmartCash Ecosystem

Incubating and expanding the SmartCash community is inherently built into each proposal. Participants enthusiastically express an excitement and willingness to elevate the SmartCash brand and its focused approach to building up entrepreneurs, solving problems, and creating a universal path to a better world. Funding has already been allocated for another 35 community-driven proposals that are poised to further increase the visibility and acceptance of SmartCash throughout the world.

"Our community-centric design allows us to tap into a diverse array of talents, enjoy major gains in efficiency, and give everyone the opportunity to make a significant impact with their unique ideas," a spokesperson for the SmartCash community stated. "As more and more people around the world join our growing community, we're excited to see all the new ways being introduced that will further increase our reach and functionality."

Accessibility to Everyone

The SmartCash community extends an open invitation to anyone who wishes to join and pitch their ideas. To learn more about the process of submitting a proposal, visit the SmartCash website and select one of the many options available to engage.

About SmartCash

SmartCash (Crypto: SMART) is a blockchain-based crypto that sets itself apart with community governance, a self-funded SmartHive Project Treasury, and mining accessibility to standard PCs. With emphasis on community involvement and merchant adoption, SmartCash aims to create the most nimble and fastest-growing crypto.

To learn more about SmartCash, visit: https://smartcash.cc/

Interactive Flipbook

To learn more about SmartCash via an interactive flipbook, visit http://smartcash.blockchainnewssource.com/flipbook/

Engage with the SmartCash Community

Discord chat via https://discord.gg/BDUh8jr 
Telegram chat via http://bit.do/smartcash 
Twitter social media via https://twitter.com/scashofficial 
Facebook social media via https://www.facebook.com/scashofficial 
YouTube via https://www.youtube.com/channel/UCzwZxu6BtWcRiQXdPqNeB5Q/featured

SmartCash Contact
SmartCash
https://smartcash.cc 
hello@smartcash.cc 

Blockchain Relations Contact
Blockchain Relations
http://www.blockchainrelations.io
614-465-6025
press@blockchainrelations.io




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SmartCash via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in October and November22.10.2018 16:00Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October and November Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session. BioStock Life Science Summit Date: October 25, 2018 Presentation Time: 18.50 Central European Time Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden Registration Link: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicum Investor Event - Gothenburg Date: October 29, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden Immunicum Investor Event - Stockholm Date: October 30, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venu

Immunicum AB (publ) meddelar kommande investerarevent under oktober och november22.10.2018 16:00Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) meddelar kommande investerarevent under oktober och november Immunicum AB (publ; IMMU.ST) meddelar i dag att bolaget kommer att anordna och delta i investerarträffar under oktober och november. Vid samtliga event kommer Carlos de Sousa, Immunicums VD, och övriga medlemmar av ledningsgruppen, att hålla en presentation av bolaget och vara tillgängliga för att svara på frågor. BioStock Life Science Summit Datum: 25 oktober 2018 Presentationstid: Kl. 18.50 CET Plats: Medicon Village, Scheelevägen 2, byggnad 302 - hörsalen, Lund Länk för registrering: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicums investerarevent - Göteborg Datum: 29 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: First Hotel G, Nils Ericsonplatsen, 411 03, Göteborg Immunicums investerarevent - Stockholm Datum: 30 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: Ingenjörshuset Citykonferensen, Plan 1, Malmski

Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress22.10.2018 12:45Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress -- Intratumoral behandling med ilixadencel, en cellbaserad, lagringsbar immunaktiverare, ger en synergistisk antitumöreffekt och förstärker effekten av behandling med anti-PD-1 och anti-CD137 i djurmodeller -- Immunicum AB (publ; IMMU.ST) presenterar under 2018 års ESMO kongress (European Society for Medical Oncology) prekliniska resultat som visar en synergistisk anti-tumöreffekt när bolagets ledande produkt ilixadencel ges i kombination med en checkpointhämmare eller immunaktiverare. Resultaten från studien, som presenteras på en poster, visar att intratumoralt administrerat ilixadencel kan förstärka anti-tumörsvar och överlevnad vid behandling med checkpointhämmare eller immunaktiverare. Detta visar på potentialen hos ilixadencel att bli en komplementerande verkningsmekanism till flera olika framtida im

Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 201822.10.2018 12:45Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 -- Intratumoral treatment with ilixadencel, an off-the-shelf cell-based immune primer, provides synergistic anti-tumor effect and enhances efficacy of anti-PD-1 and anti-CD137 treatment in animal model -- Immunicum AB (publ; IMMU.ST) announced today the presentation of preclinical results that showed anti-tumor synergy between its lead product ilixadencel and a checkpoint inhibitor or an immune enhancer in a poster at the European Society for Medical Oncology (ESMO) 2018 Congress. The results of the study highlight the ability of intratumoral ilixadencel to enhance anti-tumor response and survival of systemic checkpoint inhibitors (anti-PD-1) or immune enhancers (anti-CD137/4-1BB). This emphasizes the potential for ilixadencel in multiple future immuno-oncology combination strategies by incorporating complementary mech

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum